Study compares drug use outcomes for patients at different stages of their treatment for substance abuse
Smoking Cessation & Opioid Dependence Treatment Integration: Does Timing Matter?
School, Department, or Center
Melissa Blank Carl Sullivan, MD
The purpose of this study is to compare drug use outcomes among patients at three different stages of their SUD treatment: 0-90 days, 90 days-1 year, and more than 1 year of consistent abstinence from illicit drugs. Smokers currently in treatment for opioid dependence, at the WVU Comprehensive Opioid Addiction Treatment (COAT) program, will be recruited to participate in this 12-week study. A total of 20 patients will be recruited from each of the three COAT treatment groups, and groups will be matched on relevant demographic (e.g., age, gender) and substance use (e.g., number of cigarettes smoked per day, nicotine dependence score) characteristics. During the 12 week intervention period, individuals will continue to attend their regular COAT clinic appointments while following a standard varenicline (Chantix®) dosing regimen, responding to questions daily via text messaging (e.g., adherence to varenicline, use of tobacco, tobacco withdrawal side effects, etc.), and also interacting with a mobile-based cessation program (SmokefreeTXT). The primary outcomes will be those relevant to feasibility: 1) recruitment and retention rates, 2) adherence to treatment components (varenicline and SmokefreeTXT), and 3) compliance with responding to text message-based questions. Secondary outcomes will include a comparison of groups on the 1) proportion of relapses for all substances, 2) proportion of smokers abstinent at each assessment (confirmed with expired air carbon monoxide samples), and 3) days until successful cigarette quit day, and 4) substance withdrawal-related symptoms.
Monongalia and surrounding counties« Back to Research Initiatives